Evidence map›Paper›PMID 40423338›Full record

SynthesisToxins2025

Effect of Ochratoxin A (OTA) on the Immune System: A Systematic Review.

Yusif Mubarik, Shadrach Tetteh Boyetey, Anastasia Rosebud Aikins, Mohamed Mutocheluh

Abstract readSystematic Review
In one paragraph

Synthesis in Toxins, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Detoxification of Ochratoxin A byFoods (Basel, Switzerland) · 2026
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yusif MubarikWest African Centre for Cell Biology of Infectious Pathogens, University of Ghana, Legon, Greater Accra, Accra P.O. Box LG 54, Ghana.ORCID 0000-0001-6437-4288
Shadrach Tetteh BoyeteySchool of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi P.O. Box 256, Ghana.ORCID 0009-0002-8496-2196
Anastasia Rosebud AikinsWest African Centre for Cell Biology of Infectious Pathogens, University of Ghana, Legon, Greater Accra, Accra P.O. Box LG 54, Ghana.ORCID 0000-0001-6028-9625
Mohamed MutocheluhDepartment of Clinical Microbiology, School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi P.O. Box 256, Ghana.

Funding

WACCBIP-World Bank ACE PhD fellowship (WACCBIP+NCDs: Awandare)
6 · The paper itself

Abstract

Ochratoxin A (OTA) is a mycotoxin with different adverse health effects. The authors conducted a systematic review to evaluate the effects of OTA on the immune system, with more emphasis on its effects on immune system organs, innate and adaptive immunity and related signaling pathways. Studies have demonstrated that exposure to OTA disrupts the functions of immune system organs, resulting in weight loss, histological lesions and a decrease in antibody-secreting cells. There is evidence that OTA impairs epithelial barrier integrity and macrophage function and induces elevated secretion of pro-inflammatory cytokines. In adaptive immunity, OTA regulates T-cell differentiation, particularly Th1 and Th17 subsets, and adversely impacts humoral immunity, ultimately leading to immune suppression.

Indexed as

Immune SystemOchratoxinsAdaptive ImmunityAnimalsHumansImmunity, Innateochratoxin AOchratoxinsadaptiveimmunityinnateochratoxin A (OTA)

Identifiers

PMID40423338
PMCPMC12115609

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.